Janus Henderson Group
TARS icon

Janus Henderson Group’s Tarsus Pharmaceuticals TARS Stock Holding History

Janus Henderson Group’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$157M Buy
2,240,963
+310,638
+16% +$21.7M 0.08% 227
2025
Q4 		$158M Buy
1,930,325
+491,326
+34% +$36.7M 0.07% 220
2025
Q3 		$85.6M Sell
1,438,999
-367,948
-20% -$18.1M 0.04% 297
2025
Q2 		$73.2M Buy
1,806,947
+1,293,987
+252% +$58.2M 0.04% 318
2025
Q1 		$26.5M Buy
512,960
+500,478
+4,010% +$24.7M 0.01% 505
2024
Q4 		$691K Buy
12,482
+4,000
+47% +$182K ﹤0.01% 1874
2024
Q3 		$279K Hold
8,482
– – ﹤0.01% 2299
2024
Q2 		$230K Sell
8,482
-114
-1% -$3.83K ﹤0.01% 2343
2024
Q1 		$313K Buy
+8,596
New +$253K ﹤0.01% 2216

Other funds holding TARS

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return